Miwon Chemicals Co., Ltd. (KRX:134380)
South Korea · Delayed Price · Currency is KRW 10,400
+20 (0.19%)
Aug 10, 2026, 3:30 PM KST
Miwon Chemicals Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 306,734 | 284,512 | 256,110 | 232,616 | 235,166 | 197,470 |
Other Revenue | -0 | -0 | - | -0 | - | - |
| 306,734 | 284,512 | 256,110 | 232,616 | 235,166 | 197,470 | |
Revenue Growth | 18.99% | 11.09% | 10.10% | -1.08% | 19.09% | 23.24% |
Cost of Revenue | 252,223 | 233,641 | 207,726 | 190,419 | 199,474 | 169,830 |
Gross Profit | 54,511 | 50,872 | 48,385 | 42,197 | 35,691 | 27,640 |
Selling, General & Admin | 21,518 | 19,910 | 18,256 | 16,106 | 15,449 | 13,703 |
Research & Development | 1,291 | 1,341 | 1,166 | 884.42 | 979.53 | 833.52 |
Other Operating Expenses | 48.14 | 48.25 | 81.93 | 44.38 | 135.99 | 42.15 |
Operating Expenses | 23,335 | 21,718 | 19,750 | 17,284 | 16,708 | 14,868 |
Operating Income | 31,176 | 29,154 | 28,635 | 24,913 | 18,983 | 12,772 |
Interest Expense | - | - | - | -0.02 | -0.28 | -0.21 |
Interest & Investment Income | 1,979 | 1,988 | 1,913 | 1,145 | 383.58 | 121.19 |
Currency Exchange Gain (Loss) | 765.64 | -655.48 | 2,911 | 520 | 1,244 | 1,190 |
Other Non Operating Income (Expenses) | 415.44 | 415.29 | 292.23 | 179.6 | 459.76 | 396.04 |
EBT Excluding Unusual Items | 34,336 | 30,902 | 33,751 | 26,758 | 21,071 | 14,479 |
Gain (Loss) on Sale of Investments | 169.73 | 158.39 | 100.72 | 140.47 | -119.97 | -13.38 |
Gain (Loss) on Sale of Assets | -12.63 | -6.26 | 281.39 | 59.94 | 22.76 | -35.79 |
Asset Writedown | -8.99 | -74.03 | - | 24.53 | -34.65 | 132.63 |
Pretax Income | 34,484 | 30,980 | 34,133 | 26,983 | 20,939 | 14,563 |
Income Tax Expense | 7,082 | 6,253 | 7,203 | 5,169 | 4,678 | 3,213 |
Net Income | 27,403 | 24,726 | 26,931 | 21,814 | 16,261 | 11,350 |
Net Income to Common | 27,403 | 24,726 | 26,931 | 21,814 | 16,261 | 11,350 |
Net Income Growth | 8.34% | -8.19% | 23.46% | 34.15% | 43.26% | -17.61% |
Shares Outstanding (Basic) | 15 | 20 | 20 | 20 | 20 | 20 |
Shares Outstanding (Diluted) | 15 | 20 | 20 | 20 | 20 | 20 |
Shares Change | -22.73% | -0.01% | -1.19% | -0.79% | 0.27% | 0.66% |
EPS (Basic) | 1769.12 | 1234.63 | 1344.58 | 1076.30 | 795.88 | 557.05 |
EPS (Diluted) | 1769.10 | 1234.63 | 1344.58 | 1076.16 | 795.88 | 557.05 |
EPS Growth | 40.22% | -8.18% | 24.94% | 35.22% | 42.87% | -18.15% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 21,270 | 11,979 | 26,897 | 21,688 | 11,453 | 3,939 |
Free Cash Flow Per Share | 1373.16 | 598.13 | 1342.90 | 1069.94 | 560.59 | 193.32 |
Gross Margin | 17.77% | 17.88% | 18.89% | 18.14% | 15.18% | 14.00% |
Operating Margin | 10.16% | 10.25% | 11.18% | 10.71% | 8.07% | 6.47% |
Profit Margin | 8.93% | 8.69% | 10.51% | 9.38% | 6.91% | 5.75% |
Free Cash Flow Margin | 6.93% | 4.21% | 10.50% | 9.32% | 4.87% | 1.99% |
EBITDA | 44,791 | 42,834 | 41,726 | 38,335 | 30,515 | 24,442 |
EBITDA Margin | 14.60% | 15.05% | 16.29% | 16.48% | 12.98% | 12.38% |
D&A For EBITDA | 13,615 | 13,681 | 13,091 | 13,422 | 11,532 | 11,670 |
EBIT | 31,176 | 29,154 | 28,635 | 24,913 | 18,983 | 12,772 |
EBIT Margin | 10.16% | 10.25% | 11.18% | 10.71% | 8.07% | 6.47% |
Effective Tax Rate | 20.54% | 20.19% | 21.10% | 19.16% | 22.34% | 22.06% |
Advertising Expenses | - | 1.81 | - | 5.3 | 4.3 | 4 |